Ten Doctors on FDA Panel Reviewing Abbott Heart Device Had Financial Ties With Company
Most of the doctors the FDA tapped to advise it on an Abbott medical device had financial ties to the company. The FDA didn’t disclose the payments.
North Carolina
101 - 120 of 255 Results
-
-
ACA Plans Are Being Switched Without Enrollees’ OK
Insurance agents say it’s too easy to access consumer information on the Affordable Care Act federal marketplace. Policyholders can lose their doctors and access to prescriptions. Some end up owing back taxes.
-
Your Doctor or Your Insurer? Little-Known Rules May Ease the Choice in Medicare Advantage
Disputes between hospitals and Medicare Advantage plans are leading to entire hospital systems suddenly leaving insurance networks. Patients are left stuck in the middle, choosing between their doctors and their insurance plan. There’s a way out.
By Susan Jaffe -
After Appalachian Hospitals Merged Into a Monopoly, Their ERs Slowed to a Crawl
Ballad Health was granted the nation’s largest state-sanctioned hospital monopoly in 2018. Since then, its emergency rooms have become more than three times as slow.
By Brett Kelman and Samantha Liss -
Whistleblower Accuses Aledade, Largest US Independent Primary Care Network, of Medicare Fraud
A recently unsealed lawsuit alleges Aledade Inc. developed billing software that boosted revenues by making patients appear sicker than they were.
By Fred Schulte -
Toxic Gas That Sterilizes Medical Devices Prompts Safety Rule Update
The Environmental Protection Agency is tightening regulation of ethylene oxide, a carcinogenic gas used to sterilize medical devices. The agency is trying to balance the interests of the health care industry supply chain with those of communities where the gas creates airborne health risks.
By Andy Miller and Sam Whitehead -
Southern Lawmakers Rethink Long-Standing Opposition to Medicaid Expansion
While many Republican state lawmakers remain firmly against Medicaid expansion, some key leaders in holdout states are showing a willingness to reconsider. Public opinion, financial incentives, and widening health care needs make resistance harder.
By Daniel Chang and Andy Miller -
States Target Health Insurers’ ‘Prior Authorization’ Red Tape
Doctors, patients, and hospitals have railed for years about the prior authorization processes that health insurers use to decide whether they’ll pay for patients’ drugs or medical procedures. The Biden administration announced a crackdown in January, but some state lawmakers are looking to go further.
-
More ‘Navigators’ Are Helping Women Travel to Have Abortions
After the U.S. Supreme Court ended the federal right to an abortion and many states banned the procedure, reproductive health care organizations hired dozens of people to help patients arrange travel and pay for care.
-
Women and Minorities Bear the Brunt of Medical Misdiagnosis
Hundreds of thousands of Americans become disabled or die each year because of a diagnostic error. But some patients are at higher risk than others.
By Liz Szabo -
‘I’m Not Safe Here’: Schools Ignore Federal Rules on Restraint and Seclusion
Federal officials have long warned that restraint and seclusion in schools can be dangerous and traumatizing for children, but school districts often fail to report incidents as required by law.
-
-
Rising Malpractice Premiums Price Small Clinics Out of Gender-Affirming Care for Minors
Even in states where laws protect minors’ access to gender-affirming care, malpractice insurance premiums are keeping small and independent clinics from treating patients.
-
These Patients Had to Lobby for Correct Diabetes Diagnoses. Was Their Race a Reason?
Adults who develop one autoimmune form of diabetes are often misdiagnosed with Type 2 diabetes. Those wrong diagnoses make it harder to get the appropriate medications and technology to manage their blood sugar. Many Black patients wonder if their race plays a role.
-
Woman Petitions Health Insurer After Company Approves — Then Rejects — Her Infusions
Even people with good insurance aren't guaranteed affordable care, as this Â鶹ŮÓÅ Health News follow-up to one patient’s saga shows.
-
Cancer Patients Face Frightening Delays in Treatment Approvals
Delaying cancer treatment can be deadly — which makes the roadblock-riddled process that health insurers use to approve or deny care particularly daunting for oncology patients.
-
‘They See a Cash Cow’: Corporations Could Consume $50 Billion of Opioid Settlements
As opioid settlement dollars land in government coffers, a swarm of businesses are positioning themselves to profit from the windfall. But will their potential gains come at the expense of the settlements’ intended purpose — to remediate the effects of the opioid epidemic?
-
Dodging the Medicare Enrollment Deadline Can Be Costly
As open enrollment ends, many people are tuning out. They could wind up with a surprise next year: higher costs and less access to health care providers.
By Susan Jaffe -
Facing Financial Ruin as Costs Soar for Elder Care
The United States has no coherent system of long-term care, leading many to struggle to stay independent or rely on a patchwork of solutions.
-
Underdiagnosed and Undertreated, Young Black Males With ADHD Get Left Behind
A recent study found that young Black males are substantially more likely to be underdiagnosed and undertreated for the neurological condition than white peers.